PA
VRDN icon

Profund Advisors’s Viridian Therapeutics VRDN Stock Holding History

Profund Advisors’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Buy
63,341
+25,827
+69% +$767K 0.05% 293
2025
Q4 		$1.17M Buy
37,514
+22,183
+145% +$608K 0.04% 316
2025
Q3 		$331K Sell
15,331
-1,134
-7% -$20.5K 0.01% 692
2025
Q2 		$230K Sell
16,465
-5,878
-26% -$79.8K 0.01% 824
2025
Q1 		$301K Sell
22,343
-11,047
-33% -$188K 0.01% 670
2024
Q4 		$640K Buy
33,390
+14,934
+81% +$325K 0.02% 404
2024
Q3 		$420K Sell
18,456
-8,534
-32% -$140K 0.02% 612
2024
Q2 		$351K Sell
26,990
-36,021
-57% -$499K 0.01% 630
2024
Q1 		$1.1M Buy
63,011
+30,020
+91% +$582K 0.04% 331
2023
Q4 		$719K Sell
32,991
-10,968
-25% -$173K 0.03% 408
2023
Q3 		$674K Sell
43,959
-211
-0.5% -$4.03K 0.04% 385
2023
Q2 		$1.05M Buy
44,170
+11,270
+34% +$289K 0.06% 305
2023
Q1 		$837K Buy
+32,900
New +$1.05M 0.05% 348

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return